Literature DB >> 9414743

Ischemic damage prevention by N-acetylcysteine treatment of the donor before orthotopic liver transplantation.

F M Regueira1, J L Hernández, I Sola, J A Cienfuegos, F Pardo, A Díez-Caballero, A Sierra, E Nwose, A Espí, J Baixaúli, F Rotellar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9414743     DOI： 10.1016/s0041-1345(97)00937-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Experimental and clinical evidence for modification of hepatic ischaemia-reperfusion injury by N-acetylcysteine during major liver surgery.

Authors:  Santhalingam Jegatheeswaran; Ajith K Siriwardena
Journal:  HPB (Oxford)       Date:  2011-02       Impact factor: 3.647

2.  The Effect of Perioperative N-acetylcysteine on the Short and Long Term Outcomes in Pediatrics Undergoing Living-Donor Liver Transplantation.

Authors:  F Khalili; M B Khosravi; M A Sahmeddini; M H Eghbal; K Kazemi; S Nikeghbalian; S Ghazanfar Tehran; B Khosravi
Journal:  Int J Organ Transplant Med       Date:  2021

3.  Bucillamine, a thiol antioxidant, prevents transplantation-associated reperfusion injury.

Authors:  Farin Amersi; Sally K Nelson; Xiu Da Shen; Hirohisa Kato; Judy Melinek; Jerzy W Kupiec-Weglinski; Lawrence D Horwitz; Ronald W Busuttil; Marcus A Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.